Overview

Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effectiveness of ethyl-eicosapentanoic acid (ethyl-EPA), an omega-3 fatty acid, in treating depression.
Phase:
Phase 3
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Treatments:
Eicosapentaenoic acid ethyl ester